Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Reversal tomorrow
.46 CDN side
The revenue generating subbie appears to still be in good standing. And our boys are still listed as officers:
https://coraweb.sos.la.gov/commercialsearch/CommercialSearchDetails.aspx?CharterID=506508_94D40C803D
Can this be correct!??!?!
Shareholders
Shareholders of Record 35 a/o Nov 30, 2016
Time for some goddamn marketing now that we have a full bank account!
Still have not PRd Euro patent publication
I've seen scenarios on other plays before where those converting warrants bait in shorts expecting a liquidation, and the whole while are actually the ones soaking up the short shares on top of their existing warrant conversions. In that case the warrant holders accumulated so much that they had to file a 13g, which exposed the fact that they weren't liquidating but instead buying. This triggered one of the hardest short squeezes I have ever seen. This is the wild west after all.
900k shares shorted from March 1 - May 1 ... just saying. Next update on 24th after market close. Expecting another increase.
Good read on edibles... can see some implications for LXRP in Canadian legalization of edibles http://www.macleans.ca/politics/colorados-edible-pot-market-holds-lessons-for-canada/
New JV website up... lots of "Coming Soons"
http://www.ambariicorp.com/
I just can't wait for the 14 and 22 cent ones to finish... those are the real darts to the PPS.
Yes, I would just like to see some of them money reinvested into building some interest in the stock so that the exercise of warrants that's funding the company doesn't fall on the backs solely of the common shareholders... I understand Chris is with us and way bigger than us, but he's not going anywhere any time soon and without adequate liquidity from a solid PR game, our bid continues to bare the brunt of the discounted shares from exercised warrants.
I believe so too, but the narrative to attract a more savvy investment audience is lacking IMVHO
CDN is 4 month USA is 6 I believe... but that should only be for the original PP... Once the hold is expired then the shares become free trading and fund the subsequent warrant exercises I would think.
Cha CHING... LXRP ATM pumping out bucks for PP investors...
Sigh.
Yep, and now they have new free trading shares!
Better have some good news in the pipe to chew up the new fat
1 million more shares worth of bid whacks incoming
http://www.marketwatch.com/story/existing-warrants-exercised-for-lexaria-2017-04-27
Short position increased by 9,000 shares to 852,023
Big. Wet. Fart.
Well I'm outta dough for the moment so let's move this baby up to a buck
We went on a big run after the Calgary expo... and this one, I'd think is way huuuuger.
Private session is interesting....
One big bite and we off to the races.
freakin gumps whackin bids... reckless selling below PP
Do they ship from Canada or USA?
Garbage day, literally and figuratively.
There is a force at work here that is disconnecting the technicals from the fundamentals IMVHO. I wanna BBQ the POS IMVHO.
From FINRA daily RegSHO - this is the short volume since last reported short position of 842,743 on 03/31
Date|Symbol|ShortVolume|ShortExemptVolume|TotalVolume|Market
20170411|LXRP|131106|0|368875|O
20170410|LXRP|175319|0|807271|O
20170407|LXRP|304108|0|621845|O
20170406|LXRP|190248|0|439551|O
20170405|LXRP|41935|0|104422|O
20170404|LXRP|104348|0|336090|O
20170403|LXRP|30578|0|121024|O
__________________________________________________________
According to FINRA RegSHO data in the last 7 trading sessions there have been 977,642 shares shorted. It does not say what was covered, and what wasn't but we will see in the data update on the 15th.
Wow, there's actually a big short out there now... will have to check back in a few days and see how big it is now! WOW... this is going to get rowdy when the big news drops IMVHO...
http://www.otcmarkets.com/stock/LXRP/short-sales -----> Not sure WTF is going on with short data here but something is wonky
Come on, Chris. Give us something that will clean out the riff raff and bring in the big boys.
LXRP sucks at news.
Stop bidwhacking, TIA
Flipped the PSAR on us those hacks
Greasy action here... wow
Ah OK... check this out: http://www.lexariaenergy.com/wp-content/uploads/2015/04/Lexaria-Presentation-April-2017.pdf
Updated... Look at very bottom bullet point IMO ;) That could help :D
Horizon MMJ ETF started trading last week... I would love to see them pick up on LXRP
HMMJ ETF BREAKDOWN
The initial index has 16 members, the top 10 of which as of March 31 were;
Aurora Cannabis (TSXV: ACB) (OTC: ACBFF) at 10.6%,
Insys Therapeutics (NASDAQ: INSY) at 10.2%,
Aphria (TSX: APH) (OTC: APHQF) at 10.2%,
ScottsMiracle-Gro (NYSE: SMG) at 9.8%,
Canopy Growth (TSX: CGC) (OTC: TWMJF) at 9.7%,
GW Pharmaceuticals (NASDAQ: GWPH) at 9.6%,
Zynerba Pharmaceuticals (NASDAQ: ZYNE) at 7.4%,
Cronos Group (TSXV: MJN) (OTC: PRMCF) at 7.1%,
CanniMed Therapeutics (TSX: CMED) (OTC: CMMDF) at 5.0%
Organigram (TSXV: OGI) (OTC: OGRMF) at 4.8%.
The other six stocks are;
CannaRoyaty (CSE: CRZ) (OTC: CNNRF)
Emblem Corp. (TSXV: EMC) (OTC: EMMBF)
Emerald Health (TSXV: EMH) (OTC: TBQBF)
ICC International Cannabis Corp (TSXV: ICC) (OTC: ICCLF)
Maple Leaf Green World (TSXV: MGW) (OTC: MGWFF)
Supreme Pharmaceuticals (CSE: SL) (OTC: SPRWF).
Slightly different PR from Neutrisci that is worth posting:
NeutriSci Forms Cannabinoid Joint Venture With Lexaria Bioscience
3 hours ago - ACQUIREMEDIA
VANCOUVER, BC -- (Marketwired) -- 04/10/17 -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) and Lexaria Bioscience Corp. ("Lexaria") (CSE: LXX) (OTCQB: LXRP) are pleased to announce finalization of the joint venture between the companies to produce and commercialize a line of healthy, sugar-free, edible cannabinoid sublingual tablets combining NeutriSci's proprietary pterostilbene tablet form factor and Lexaria's patented technology.
The new company to be formed, Ambarii Trade Corporation ("Ambarii"), is initially being funded and owned equally by each of NeutriSci and Lexaria. NeutriSci and Lexaria are each contributing its respective technology to Ambarii by way of a license, and will split all profits derived from Ambarii operations on a 50/50 basis.
Ambarii will immediately work to secure licensees in California, Colorado and Canada, to manufacture and sell sublingual melt tablets containing THC and CBD. The products will also combine the benefits of both NeutriSci's and Lexaria's existing technologies and ingredient mixes. Initial manufacturing arrangements have been secured with a licensed entity in California which will begin large scale test runs in May, 2017 with plans to manufacture and test a fully functioning THC and CBD version of the product. In more developed legal markets such as California and Colorado, cannabis edibles often comprise 33% - 55% market share of all legal cannabis products, making high quality cannabis edibles vitally important to the marketplace.
Ambarii will also enter the hemp oil based market for sublingual melt products, which are not as highly regulated in some jurisdictions as THC-based products. Distribution for these products will be developed through NeutriSci's existing network of retail distributors as well as other methods. Initial test production runs of the hemp oil variety of pterostilbene-containing products have already achieved very positive human focus group results, as previously announced.
Glen Rehman, President of NeutriSci stated, "We are thrilled to officially partner with Lexaria. As we continue our advanced discussions with some of Canada's leading medical marijuana companies, this JV Agreement represents a giant leap forward for the development, sale and manufacturing of cannabis edibles. Ambarii will deliver an edible product that is not only highly effective, but also a healthy sugar free alternative powered by pterostilbene. The Ambarii product line will be world class, and will have high appeal to today's health conscious medicinal and recreational users."
On Behalf of the Board of Directors of
NEUTRISCI INTERNATIONAL INC.
Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com
Couple of rookie ass hats trying to blow their whole load at one time on the ask... sad part is they probably sitting there scratching their heads wondering why their shares aren't selling...